Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population ; volume:12 ; number:1 ; day:5 ; month:1 ; year:2012 ; pages:1-9 ; date:12.2012
BMC gastroenterology ; 12, Heft 1 (5.1.2012), 1-9, 12.2012
- Contributor
-
Sumida, Yoshio
Yoneda, Masato
Hyogo, Hideyuki
Itoh, Yoshito
Ono, Masafumi
Fujii, Hideki
Eguchi, Yuichiro
Suzuki, Yasuaki
Aoki, Noriaki
Kanemasa, Kazuyuki
Fujita, Koji
Chayama, Kazuaki
Saibara, Toshiji
Kawada, Norifumi
Fujimoto, Kazuma
Kohgo, Yutaka
Yoshikawa, Toshikazu
Okanoue, Takeshi
SpringerLink (Online service)
- DOI
-
10.1186/1471-230X-12-2
- URN
-
urn:nbn:de:1111-201607156750
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sumida, Yoshio
- Yoneda, Masato
- Hyogo, Hideyuki
- Itoh, Yoshito
- Ono, Masafumi
- Fujii, Hideki
- Eguchi, Yuichiro
- Suzuki, Yasuaki
- Aoki, Noriaki
- Kanemasa, Kazuyuki
- Fujita, Koji
- Chayama, Kazuaki
- Saibara, Toshiji
- Kawada, Norifumi
- Fujimoto, Kazuma
- Kohgo, Yutaka
- Yoshikawa, Toshikazu
- Okanoue, Takeshi
- SpringerLink (Online service)
Other Objects (12)
Nonalcoholic fatty liver disease test: an external validation cohort
Non-alcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Artificial intelligence in nonalcoholic fatty liver disease
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk
Nonalcoholic fatty liver disease test: an external validation cohort
Non-alcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Artificial intelligence in nonalcoholic fatty liver disease
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota
Nonalcoholic fatty liver disease and cardiovascular disease risk
Nonalcoholic fatty liver disease test: an external validation cohort
Non-alcoholic fatty liver disease
Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity
Artificial intelligence in nonalcoholic fatty liver disease
Hepatic Innervations and Nonalcoholic Fatty Liver Disease
Multiomics study of nonalcoholic fatty liver disease
Role of bioactive fatty acids in nonalcoholic fatty liver disease
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Bioengineering liver microtissues for modeling non-alcoholic fatty liver disease
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease, diet and gut microbiota